Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin
- 19 March 2004
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 150 (3) , 596-597
- https://doi.org/10.1111/j.1365-2133.2003.05795.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Scleromyxoedema-like changes in four renal dialysis patientsBritish Journal of Dermatology, 2003
- Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease)Journal of the American Academy of Dermatology, 2003
- Clinical and pathologic features of nephrogenic fibrosing dermopathy: A report of two casesJournal of the American Academy of Dermatology, 2003
- Scleromyxedema‐like fibromucinosis in a patient undergoing hemodialysisInternational Journal of Dermatology, 2002
- Intravenous immunoglobulins control scleromyxoedemaAnnals of the Rheumatic Diseases, 2002
- Nephrogenic Fibrosing DermopathyThe American Journal of Dermatopathology, 2001
- High-dose intravenous immunoglobulins: An approach to treat severe immune-mediated and autoimmune diseases of the skinJournal of the American Academy of Dermatology, 2001
- Scleromyxoedema-like cutaneous diseases in renal-dialysis patientsPublished by Elsevier ,2000
- Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg)Journal of the American Academy of Dermatology, 2000